| # | Drug | Count |
|---|---|---|
| 0 | VENETOCLAX | 87 |
| 1 | APIXABAN | 59 |
| 2 | ASPIRIN | 33 |
| 3 | DEXAMETHASONE | 31 |
| 4 | DEXAMETHASONE 1.5 MG | 31 |
| 5 | ASPIRIN 325 MG | 30 |
| 6 | ASPIRIN 81 MG | 30 |
| 7 | AZACITIDINE | 30 |
| 8 | CYCLOPHOSPHAMIDE | 28 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYCOL, UNSPECIFIED | 1 | 0.0100 |
| 1 | CEDAZURIDINE AND DECITABINE | 8 | 0.0082 |
| 2 | DEXRAZOXANE FOR INJECTION | 3 | 0.0032 |
| 3 | BELINOSTAT | 1 | 0.0028 |
| 4 | DINUTUXIMAB | 2 | 0.0023 |
| 5 | AMIKACIN SULFATE | 4 | 0.0023 |
| 6 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 5 | 0.0021 |
| 7 | PLERIXAFOR | 3 | 0.0020 |
| 8 | REVUMENIB | 2 | 0.0019 |
| 9 | MESNA INJECTION | 16 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 87 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 74 |
| 2 | Factor Xa Inhibitor [EPC] | 69 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 59 |
| 4 | Corticosteroid [EPC] | 50 |
| 5 | Platinum-based Drug [EPC] | 40 |
| 6 | Alkylating Drug [EPC] | 38 |
| 7 | Azole Antifungal [EPC] | 34 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 33 |
| 9 | Loop Diuretic [EPC] | 32 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 5 | 0.0021 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 3 | 0.0020 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 3 | Antifibrinolytic Agent [EPC] | 16 | 0.0016 |
| 4 | BCL-2 Inhibitor [EPC] | 87 | 0.0014 |
| 5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 6 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 2 | 0.0011 |
| 7 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 2 | 0.0009 |
| 8 | Bile Acid [EPC] | 14 | 0.0006 |
| 9 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |